跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RINGZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RINGZA
Authorized
STANDARD
RINGZA
Duchesnay Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
338754e0527a2111
Company
Duchesnay Inc
Type
Standard
Approval Details
Approval Id
338754e0527a2111
Drug Approval Canada Name
RINGZA
Product Name
RINGZA
Status
Approved
Status Date
2024-12-18
Din
02554070
Drug Class
Human
Dosage Form
Ring (Slow-Release)
Route Of Administration
Vaginal
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN
Atc Name
g 02 bb 01
Aig Number
0266384001
Company Name
Duchesnay Inc
Company Address
950 Michele-Bohec Blvd, Blainville, Quebec, Canada, J7C 5E2
Company Detail Path
/organization/duchesnay-inc
Company Information
Pharmaceutical Company Name
Duchesnay Inc
Country Name
Canada
Province Name
Quebec
City Name
blainville,quebec,country_ca
Address
950 boul Michèle-Bohec
Active Ingredients
ETHINYL ESTRADIOL
17.4 MG
SEGESTERONE ACETATE
103 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
338754e0527a2111
Type
Standard
Back to Health Canada Approvals